Boothbay Fund Management’s bioAffinity Technologies BIAFW Stock Holding History

Boothbay Fund Management’s Portfolio BIAFW Stock Details BIAFW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-12,500	Closed	-$36K	–	2009
2022 Q3	$36K	Buy	+12,500	New	+$13K	﹤0.01%	2136

Other funds holding BIAFW

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Boothbay Fund Management's BIAFW Position: Q4 2022 in Review

Boothbay Fund Management sold out of bioAffinity Technologies (BIAFW) in Q4 2022, closing a stake of 12,500 shares — an estimated $36K sold.

Boothbay Fund Management first reported a position in BIAFW in Q3 2022 and held it in 1 quarter. The position peaked at $36K in Q3 2022. 5 funds tracked by Wall St. Rank hold BIAFW as of Q4 2022.

Boothbay Fund Management reported no remaining bioAffinity Technologies position as of Q4 2022 after selling out during the quarter.
Boothbay Fund Management sold 12,500 bioAffinity Technologies shares in Q4 2022, an estimated $36K.
Boothbay Fund Management first reported a position in bioAffinity Technologies in Q3 2022 and held it in 1 quarter.
Boothbay Fund Management's bioAffinity Technologies position peaked at $36K in Q3 2022.
5 funds tracked by Wall St. Rank held bioAffinity Technologies as of Q4 2022.

Based on Boothbay Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.